| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CODEXIS, INC. | Director | Common Stock | 143,583 | $361,829 | $2.52 | 10 Jun 2025 | Direct |
| SANGAMO THERAPEUTICS, INC | Director | Common Stock | 112,600 | $51,796 | $0.4600 | 12 Jun 2025 | Direct |
| IMPEL NEUROPHARMA INC | Director | Common Stock | 20,151 | $5,844 | $0.2900 | 27 Apr 2021 | Direct |
| SANGAMO THERAPEUTICS, INC | Director | Stock Option (Right to Buy) | 50,000 | 12 Jun 2025 | Direct | ||
| IMPEL PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 12,789 | 16 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SGMO | SANGAMO THERAPEUTICS, INC | 12 Jun 2025 | 2 | $0 | 4 | Director | 16 Jun 2025, 16:05 |
| CDXS | CODEXIS, INC. | 10 Jun 2025 | 1 | $0 | 4 | Director | 12 Jun 2025, 19:29 |
| CDXS | CODEXIS, INC. | 11 Jun 2024 | 1 | $0 | 4 | Director | 13 Jun 2024, 18:27 |
| SGMO | SANGAMO THERAPEUTICS, INC | 04 Jun 2024 | 2 | $0 | 4 | Director | 06 Jun 2024, 16:25 |
| CDXS | CODEXIS, INC. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 16:08 |
| SGMO | SANGAMO THERAPEUTICS, INC | 01 Jun 2023 | 2 | $0 | 4 | Director | 05 Jun 2023, 16:51 |
| CDXS | CODEXIS, INC. | 16 Dec 2022 | 1 | $0 | 4 | Director | 20 Dec 2022, 15:41 |
| CDXS | CODEXIS, INC. | 16 Dec 2022 | 0 | $0 | 3 | Director | 20 Dec 2022, 15:41 |
| IMPL | IMPEL PHARMACEUTICALS INC | 16 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 17:02 |
| SGMO | SANGAMO THERAPEUTICS, INC | 01 Jun 2022 | 1 | +$17,996 | 4 | Director | 03 Jun 2022, 16:18 |
| SGMO | SANGAMO THERAPEUTICS, INC | 25 Feb 2022 | 2 | $0 | 4 | Director | 01 Mar 2022, 16:12 |
| IMPL | IMPEL NEUROPHARMA INC | 11 Jul 2021 | 1 | $0 | 4 | Director | 13 Jul 2021, 17:09 |
| IMPL | IMPEL NEUROPHARMA INC | 27 Apr 2021 | 0 | $0 | 4/A | Director | 22 Jun 2021, 17:47 |
| IMPL | IMPEL NEUROPHARMA INC | 22 Apr 2021 | 0 | $0 | 3/A | Director | 22 Jun 2021, 17:41 |